BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34916290)

  • 21. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EMT and acquisition of stem cell-like properties are involved in spontaneous formation of tumorigenic hybrids between lung cancer and bone marrow-derived mesenchymal stem cells.
    Xu MH; Gao X; Luo D; Zhou XD; Xiong W; Liu GX
    PLoS One; 2014; 9(2):e87893. PubMed ID: 24516569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene expression profiling of single circulating tumor cells in ovarian cancer - Establishment of a multi-marker gene panel.
    Blassl C; Kuhlmann JD; Webers A; Wimberger P; Fehm T; Neubauer H
    Mol Oncol; 2016 Aug; 10(7):1030-42. PubMed ID: 27157930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In silico identification of thiostrepton as an inhibitor of cancer stem cell growth and an enhancer for chemotherapy in non-small-cell lung cancer.
    Huang TH; Wu ATH; Cheng TS; Lin KT; Lai CJ; Hsieh HW; Chang PM; Wu CW; Huang CF; Chen KY
    J Cell Mol Med; 2019 Dec; 23(12):8184-8195. PubMed ID: 31638335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition.
    Lin SH; Wang J; Saintigny P; Wu CC; Giri U; Zhang J; Menju T; Diao L; Byers L; Weinstein JN; Coombes KR; Girard L; Komaki R; Wistuba II; Date H; Minna JD; Heymach JV
    BMC Genomics; 2014 Dec; 15(1):1079. PubMed ID: 25486910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity.
    Bota-Rabassedas N; Banerjee P; Niu Y; Cao W; Luo J; Xi Y; Tan X; Sheng K; Ahn YH; Lee S; Parra ER; Rodriguez-Canales J; Albritton J; Weiger M; Liu X; Guo HF; Yu J; Rodriguez BL; Firestone JJA; Mino B; Creighton CJ; Solis LM; Villalobos P; Raso MG; Sazer DW; Gibbons DL; Russell WK; Longmore GD; Wistuba II; Wang J; Chapman HA; Miller JS; Zong C; Kurie JM
    Cell Rep; 2021 Apr; 35(3):109009. PubMed ID: 33882319
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ZEB1-responsive genes in non-small cell lung cancer.
    Gemmill RM; Roche J; Potiron VA; Nasarre P; Mitas M; Coldren CD; Helfrich BA; Garrett-Mayer E; Bunn PA; Drabkin HA
    Cancer Lett; 2011 Jan; 300(1):66-78. PubMed ID: 20980099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.
    Parsana P; Amend SR; Hernandez J; Pienta KJ; Battle A
    BMC Cancer; 2017 Jun; 17(1):447. PubMed ID: 28651527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EML4-ALK induces epithelial-mesenchymal transition consistent with cancer stem cell properties in H1299 non-small cell lung cancer cells.
    Guo F; Liu X; Qing Q; Sang Y; Feng C; Li X; Jiang L; Su P; Wang Y
    Biochem Biophys Res Commun; 2015 Apr; 459(3):398-404. PubMed ID: 25735977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC): phenotypical and functional differences associated with Epithelial-Mesenchymal Transition (EMT) and DNA methylation changes.
    Krohn A; Ahrens T; Yalcin A; Plönes T; Wehrle J; Taromi S; Wollner S; Follo M; Brabletz T; Mani SA; Claus R; Hackanson B; Burger M
    PLoS One; 2014; 9(6):e100249. PubMed ID: 24959847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
    Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
    Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
    BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of prognostic markers for hepatocellular carcinoma based on the epithelial-mesenchymal transition-related gene BIRC5.
    Xu R; Lin L; Zhang B; Wang J; Zhao F; Liu X; Li Y; Li Y
    BMC Cancer; 2021 Jun; 21(1):687. PubMed ID: 34112092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene.
    Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J
    Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncogenic ALK regulates EMT in non-small cell lung carcinoma through repression of the epithelial splicing regulatory protein 1.
    Voena C; Varesio LM; Zhang L; Menotti M; Poggio T; Panizza E; Wang Q; Minero VG; Fagoonee S; Compagno M; Altruda F; Monti S; Chiarle R
    Oncotarget; 2016 May; 7(22):33316-30. PubMed ID: 27119231
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transcription factor E2F1 promotes EMT by regulating ZEB2 in small cell lung cancer.
    Wang T; Chen X; Qiao W; Kong L; Sun D; Li Z
    BMC Cancer; 2017 Nov; 17(1):719. PubMed ID: 29115924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung Cancer.
    Sugano T; Seike M; Noro R; Soeno C; Chiba M; Zou F; Nakamichi S; Nishijima N; Matsumoto M; Miyanaga A; Kubota K; Gemma A
    Mol Cancer Ther; 2015 Nov; 14(11):2433-40. PubMed ID: 26351321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.